NASDAQ:MTEM

Molecular Templates SEC Filings & 10K Form

$8.92
+0.41 (+4.82 %)
(As of 05/11/2021 12:00 AM ET)
Add
Compare
Today's Range
$8.12
$8.96
50-Day Range
$7.82
$12.70
52-Week Range
$7.51
$18.34
Volume196,771 shs
Average Volume438,055 shs
Market Capitalization$500.30 million
P/E RatioN/A
Dividend YieldN/A
Beta2.08

SEC Filings

Molecular Templates (NASDAQ:MTEM) SEC Filings

DateFilerForm TypeView
04/27/2021
6:00 AM
Molecular Templates (Filer)
Form DEF 14A
04/26/2021
12:11 PM
BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
04/21/2021
10:22 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2021
12:14 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2021
11:26 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/13/2021
2:51 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2021
12:52 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2021
12:13 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/05/2021
6:38 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2021
12:44 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2021
5:52 AM
Molecular Templates (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/19/2021
5:10 AM
Molecular Templates (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/25/2021
1:46 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/22/2021
3:36 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/19/2021
4:28 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2021
4:00 PM
Molecular Templates (Filer)
Form 424B5
02/17/2021
4:02 PM
Cutler Adam D. (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:55 PM
Molecular Templates (Issuer)
Poma Eric E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/17/2021
3:14 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/16/2021
2:41 PM
Molecular Templates (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13G/A
02/12/2021
4:07 PM
BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
02/11/2021
4:23 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
02/11/2021
6:36 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2021
12:33 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/01/2021
3:58 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2021
7:00 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2020
11:36 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2020
5:30 AM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
3:09 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2020
5:04 AM
Molecular Templates (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/05/2020
3:32 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2020
2:05 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2020
7:53 PM
BB BIOTECH AG (Reporting)
BIOTECH TARGET N V (Reporting)
Molecular Templates (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2020
3:39 PM
LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/18/2020
3:38 PM
Cunningham Joe H (Reporting)
FRENCH DOUGLAS D (Reporting)
Molecular Templates (Issuer)
Sante Health Ventures I Annex Fund, LP (Reporting)
SANTE HEALTH VENTURES I LP (Reporting)
SHV Annex Services, LP (Reporting)
SHV Management Services, LLC (Reporting)
SHV Management Services, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/01/2020
6:33 PM
ENRIGHT PATRICK G (Reporting)
Longitude Capital Partners III, LLC (Reporting)
Longitude Venture Partners III, L.P. (Reporting)
Molecular Templates (Issuer)
Tammenoms Bakker Juliet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/17/2020
11:15 PM
Molecular Templates (Filer)
Form EFFECT
08/17/2020
3:21 PM
Molecular Templates (Filer)
Form 424B5
08/07/2020
6:19 AM
Molecular Templates (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/07/2020
6:00 AM
Molecular Templates (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/20/2020
3:30 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2020
11:15 PM
Molecular Templates (Filer)
Form EFFECT
06/16/2020
3:32 PM
Molecular Templates (Filer)
Form S-3/A
06/05/2020
4:11 PM
Longitude Capital Partners III, LLC (Filed by)
Molecular Templates (Subject)
Form SC 13D/A
06/04/2020
3:42 PM
Molecular Templates (Filer)
Form S-3
Registration statement under Securities Act of 1933  
06/01/2020
4:09 PM
Molecular Templates (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:09 PM
LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:09 PM
Hirsch David (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:06 PM
Molecular Templates (Issuer)
Morenstein Scott D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:05 PM
Molecular Templates (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
8:13 PM
Hirsch David (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
8:07 PM
ENRIGHT PATRICK G (Reporting)
Longitude Capital Partners III, LLC (Reporting)
Longitude Venture Partners III, L.P. (Reporting)
Molecular Templates (Issuer)
Tammenoms Bakker Juliet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2020
4:10 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2020
3:16 PM
Cunningham Joe H (Reporting)
FRENCH DOUGLAS D (Reporting)
Molecular Templates (Issuer)
Sante Health Ventures I Annex Fund, LP (Reporting)
SANTE HEALTH VENTURES I LP (Reporting)
SHV Annex Services, LP (Reporting)
SHV Management Services, LLC (Reporting)
SHV Management Services, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/22/2020
7:20 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2020
5:00 AM
Molecular Templates (Filer)
Form NT 10-Q
04/23/2020
3:05 PM
Molecular Templates (Filer)
Form DEF 14A
03/13/2020
9:27 AM
Molecular Templates (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/18/2020
8:59 PM
Molecular Templates (Issuer)
Waltzman Roger J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
8:59 PM
Cutler Adam D. (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
8:59 PM
Molecular Templates (Issuer)
Poma Eric E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2020
8:58 PM
Kim Jason S. (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2020
2:21 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
01/29/2020
3:34 PM
BB BIOTECH AG (Filed by)
Molecular Templates (Subject)
Form SC 13G
01/03/2020
3:41 PM
Kim Jason S. (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
7:05 AM
Molecular Templates (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2019
7:00 AM
Molecular Templates (Issuer)
Sanders Corazon D. (0001796536) (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/19/2019
4:23 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2019
3:29 PM
Longitude Capital Partners III, LLC (Filed by)
Molecular Templates (Subject)
Form SC 13D/A
12/05/2019
3:16 PM
Hirsch David (Reporting)
Molecular Templates (Issuer)
Form 4/A
12/05/2019
3:16 PM
ENRIGHT PATRICK G (Reporting)
Longitude Capital Partners III, LLC (Reporting)
Longitude Venture Partners III, L.P. (Reporting)
Molecular Templates (Issuer)
Tammenoms Bakker Juliet (Reporting)
Form 4/A
11/27/2019
3:47 PM
ENRIGHT PATRICK G (Reporting)
Longitude Capital Partners III, LLC (Reporting)
Longitude Venture Partners III, L.P. (Reporting)
Molecular Templates (Issuer)
Tammenoms Bakker Juliet (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
3:43 PM
Hirsch David (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2019
10:38 AM
Molecular Templates (Filer)
Form D
Notice of Exempt Offering of Securities 
11/25/2019
3:24 PM
CAXTON CORP (Reporting)
CDK ASSOCIATES, L.L.C. (Reporting)
Kovner Bruce (Reporting)
Molecular Templates (Issuer)
Morenstein Scott D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2019
8:01 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/22/2019
6:37 PM
Molecular Templates (Filer)
Form 424B5
11/20/2019
3:48 PM
Molecular Templates (Filer)
Form 424B5
11/18/2019
6:09 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
4:00 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2019
7:01 AM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2019
3:32 PM
Molecular Templates (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/12/2019
3:30 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/30/2019
7:04 PM
LALANDE KEVIN M. (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
7:02 PM
HOFFMANN DAVE (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
6:58 PM
Molecular Templates (Issuer)
Morenstein Scott D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
6:57 PM
Molecular Templates (Issuer)
SELICK HAROLD E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2019
6:55 PM
Hirsch David (Reporting)
Molecular Templates (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
3:34 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/13/2019
3:45 PM
Molecular Templates (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/13/2019
3:02 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/29/2019
3:45 PM
Molecular Templates (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/29/2019
3:14 PM
Molecular Templates (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2019
3:30 PM
Molecular Templates (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2019
11:40 AM
Molecular Templates (Filer)
Form CT ORDER
02/21/2019
3:56 PM
Molecular Templates (Issuer)
Waltzman Roger J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
3:31 PM
Molecular Templates (Issuer)
Waltzman Roger J. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
02/14/2019
3:29 PM
BIOTECHNOLOGY VALUE FUND L P (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
02/13/2019
3:15 PM
Molecular Templates (Filer)
Form 10-Q/A
02/06/2019
8:44 AM
Excel Venture Fund II, L.P. (Filed by)
Molecular Templates (Subject)
Form SC 13G/A
This page was last updated on 5/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.